Interested in learning more about Hyfe? Read about all of our news, announcements and updates here!
Comprehensive Chronic Cough Report reveals $15B opportunity. 100M patients, zero FDA-approved drugs, positioning digital cough monitoring as essential pharma infrastructure.
Review including Hyfe research evaluates continuous digital cough monitoring as a practical way to address limitations of patient-reported cough data
Study results demonstrate digital Behavioral Cough Suppression Therapy reduced cough frequency by over 40% in patients with refractory and unexplained chronic cough.
Strategic partnership with KYORIN Pharmaceuticals aims to improve outcomes and expand treatment access to millions impacted by chronic cough globally.
The New Cough Management Feature is based on decades of scientific evidence and is expected to empower millions of coughers with the tools to help manage Chronic Cough
CoughPro app introduces the world’s first digital Cough Management feature, offering AI-driven solutions for millions suffering from chronic cough
Wilmington, Del., Sep 9, 2024 -- CoughPro, the global leader in consumer cough tracking and monitoring, proudly announces the launch of its pioneering Cough Management feature, marking a global first in digital wellness. Cough Management is now available within the CoughPro app, offering science-based, actionable lifestyle and behavioral content for individuals struggling with chronic cough conditions.
Powered by the principles of Behavioral Cough Suppression and Hyfe’s state-of-the-art cough detection, CoughPro’s Cough Management leverages cutting-edge AI technology to offer users a science-backed approach to taking control of their cough. As the go-to tool for thousands of users worldwide, CoughPro continues to set the standard for cough monitoring in a wellness setting, now expanding its scope to include support for daily Cough Management.
Chronic cough, particularly refractory or unexplained chronic cough, affects about 1 in 10 people in the United States1. CoughPro’s Cough Management feature provides these individuals with a way to live better with their cough, integrating evidence-based techniques2 used by speech and language pathologists.
CoughPro’s Cough Management Tool introduces users to the “3 Rs” framework of Cough Management:
Users benefit from educational content, interactive lessons, and practical exercises designed to help them better understand their cough and take proactive steps to manage it. The feature includes audio guides, video demonstrations, and feedback mechanisms to ensure users master the techniques.
We are excited to give our users the means to take action on their chronic cough. Our mission has always been to empower individuals with tools they need to improve their wellbeing. Cough Management represents a significant step forward in Hyfe’s commitment to bettering the lives of people with chronic cough.
Reid Moorsmith
Hyfe’s CXO
CoughPro is the leading consumer app for cough tracking and monitoring, using state-of-the-art AI technology developed by Hyfe. With thousands of users worldwide, CoughPro is committed to providing accurate and reliable cough data, helping users and healthcare professionals better understand and manage cough conditions.
For more information, visit www.coughpro.com or contact press@coughpro.com.
***
CoughPro – and the Cough Management feature – is currently available as a wellness app and is not intended to diagnose, treat, cure, or prevent any disease. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA) as a medical device or treatment. Users are advised to consult with a healthcare professional before making any medical decisions about their cough.
References:
1 The exact prevalence of chronic cough ranges in literature anywhere between 5% and 18%. This publication puts the United States’ number at 9.6%.
2 Evidence for the effectiveness of cough suppression therapy: RCT1, RCT2 and RCT3 on combination therapy.
